Document ID: SEC-2006-1491-0001
Agency: sec
Document Type: Notice
Title: HealthShares, Inc., et al.; Notice of Application
Posted Date: 2006-11-21T05:00Z

[Federal Register: November 21, 2006 (Volume 71, Number 224)]
[Notices]               
[Page 67404-67408]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr21no06-75]                         

=======================================================================
-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Investment Company Act Release No. 27553; 812-13264]

 
HealthShares, Inc., et al.; Notice of Application

November 16, 2006.
AGENCY: Securities and Exchange Commission (``Commission'').

ACTION: Notice of an application for an order under section 6(c) of the 
Investment Company Act of 1940 (``Act'') for an exemption from sections 
2(a)(32), 5(a)(1), 22(d), and 24(d) of the Act and rule 22c-1 under the 
Act, and under sections 6(c) and 17(b) of the Act for an exemption from 
sections 17(a)(1) and 17(a)(2) of the Act.

-----------------------------------------------------------------------

    Summary of Application: Applicants request an order granting relief 
to permit (a) an open-end management investment company, the series of 
which consist of the component securities of certain equity securities 
indexes, to issue shares (``Shares'') that can be redeemed only in 
large aggregations (``Creation Units''), (b) secondary market 
transactions in Shares to occur at negotiated prices on a national 
securities exchange, as defined in section 2(a)(26) of the Act 
(``Exchange''), (c) dealers to sell Shares to purchasers in the 
secondary market unaccompanied by a prospectus when prospectus delivery 
is not required by the Securities Act of 1933 (``Securities Act''), and 
(d) certain affiliated persons of the series to deposit securities 
into, and receive securities from, the series in connection with the 
purchase and redemption of Creation Units.
    Applicants: HealthShares, Inc. (``Corporation''), Ferghana-
Wellspring LLC (``Index Creator''), and X-Shares Advisors, LLC 
(``Advisor'').

DATES: Filing Dates: The application was filed on March 1, 2006, and 
amended on August 23, 2006 and November 15, 2006.
    Hearing or Notification of Hearing: An order granting the 
application will be issued unless the Commission orders a hearing. 
Interested persons may request a hearing by writing to the Commission's 
Secretary and serving applicants with a copy of the request, personally 
or by mail. Hearing requests should be received by the Commission by 
5:30 p.m. on December 6, 2006, and should be accompanied by proof of 
service on applicants, in the form of an affidavit, or for lawyers, a 
certificate of service. Hearing requests should state the nature of the 
writer's interest, the reason for the request, and the issues 
contested. Persons who wish to be notified of a hearing may request 
notification by writing to the Commission's Secretary.

ADDRESSES: Secretary, U.S. Securities and Exchange Commission, 100 F 
Street, NE., Washington, DC 20549-1090; Applicants, 420 Lexington 
Avenue, Suite 2550, New York, NY 10170.

FOR FURTHER INFORMATION CONTACT: Shannon Conaty, Senior Counsel, at 
(202) 551-6827, or Mary Kay Frech, Branch Chief, at (202) 551-6821 
(Division of Investment Management, Office of Investment Company 
Regulation).

SUPPLEMENTARY INFORMATION: The following is a summary of the 
application. The complete application may be obtained for a fee at the 
Public Reference Desk, U.S. Securities and Exchange Commission, 100 F 
Street, NE., Washington DC 20549-0102 (telephone (202) 551-5850).

Applicants' Representations

    1. The Corporation, a Maryland corporation, is registered under the 
Act as an open-end management investment company. Applicants currently 
intend to introduce 20 series (``Initial Funds'') of the Corporation 
and may establish additional series in the future (``Future Funds,'' 
and together with the Initial Funds, ``Funds''). The Advisor, a wholly-
owned subsidiary of the Index Creator, is registered as an investment 
adviser under the Investment Advisers Act of 1940 (``Advisers Act'') 
and will serve as the investment adviser to each Fund.\1\ The Advisor 
expects to enter into a sub-advisory agreement with BNY Investment 
Advisors to serve as sub-adviser (``Sub-Advisor'') to the Funds. The 
Sub-Advisor is not otherwise an affiliated person of the Advisor or the 
Index Creator and is registered as an investment adviser under the 
Advisers Act. ALPS Distributors, Inc., a broker-

[[Page 67405]]

dealer registered under the Securities Exchange Act of 1934 (``Exchange 
Act''), will serve as principal underwriter for the Funds (the 
``Distributor'').
---------------------------------------------------------------------------

    \1\ Neither the Index Creator nor the Advisor nor any affiliated 
person of the Index Creator or the Advisor is or will be registered 
as a broker or dealer.
---------------------------------------------------------------------------

    2. Each Fund seeks to invest in a portfolio of equity securities 
(``Portfolio Securities'') that substantially replicate a particular 
benchmark (each an ``Index'' or ``Underlying Index'' and collectively, 
the ``Indices'' or ``Underlying Indices''). The Underlying Indices are 
based on a proprietary, rules-based methodology developed by the Index 
Creator to define certain segments of the healthcare, life sciences and 
biotechnology sectors of both domestic and international markets 
(``Methodology'').\2\ The Methodology, including the rules which govern 
the inclusion and weighting of securities in the Underlying Indices, 
will be publicly available, including on either the Advisor's or the 
Funds' website (``Web site''), along with the identities and weightings 
of the component securities of each Index (``Component Securities'') 
and the Portfolio Securities of each Fund.\3\ While the Index Creator 
may change the rules of the Methodology in the future, the Index 
Creator presently does not intend to do so. Any change to the 
Methodology would not take effect until the Index Creator had given the 
public at least 60 days advance notice of the change and had given 
reasonable notice of the change to the Index Administrator/Calculation 
Agent. The ``Index Administrator/Calculation Agent'' is the entity 
that, pursuant to an agreement with the Index Creator, is solely 
responsible for all Index calculation, maintenance, dissemination and 
reconstitution activities.\4\ The Administrator/Calculation Agent is 
not, and will not be, an affiliated person, or an affiliated person of 
an affiliated person, of the Funds, Advisor, Sub-Advisor, Index 
Creator, any promoter of the Funds, or the Distributor of the Funds.\5\
---------------------------------------------------------------------------

    \2\ Each Underlying Index is developed using an investment 
approach known as ``Vertical Investing,'' which seeks to categorize 
companies within a particular healthcare, life sciences or 
biotechnology index by focusing on each company's business 
activities with regard to the diagnosis of diseases, the development 
of drugs, treatments, therapies and delivery systems, and the 
development of enabling/research tools and technologies for use in 
these sectors.
    \3\ The Index Creator, as owner of the Indices and all 
intellectual property related to them, intends to license the 
Indices to the Advisor for use in connection with the Funds. The 
license will specifically state that the Advisor must provide the 
use of the Indices to the Funds at no cost.
    \4\ The Index Administrator/Calculation Agent will determine the 
number, type and weight of securities that comprise each Index and 
perform, or cause to be performed, all other calculations that are 
necessary to determine the proper constitution of each Index. The 
Index Administrator/Calculation Agent will not disclose any 
information about any Index's constitution to the Index Creator, the 
Advisor, the Sub-Advisor or the Funds prior to the publication of 
such information on the Website. However, the Index Administrator/
Calculation Agent may disclose such information solely to certain 
employees of the Index Creator and its affiliates who will monitor 
the Methodology and the Indices (``Index Personnel'') and to the 
chief compliance officer of the Funds, the Advisor and the Sub-
Advisor for purposes of monitoring compliance with the code of 
ethics of these entities.
    \5\ Standard & Poor's (``S&P'') will serve as Index 
Administrator/Calculation Agent for the Underlying Indices.
---------------------------------------------------------------------------

    3. Applicants state that the Index Personnel will not have any 
responsibility for the management of the Funds. In addition, applicants 
have adopted policies and procedures that, among other things, are 
designed to limit or prohibit communications between the Index 
Personnel and other employees of the Index Creator and the Advisor or 
any Sub-Advisor (``Firewalls''). Among other things, the Firewalls 
prohibit the Index Personnel from disseminating non-public information 
about the Indices, including potential changes to the Methodology, to, 
among others, the employees of the Advisor or any Sub-Advisor 
responsible for managing the Funds (``advisory personnel''). The 
Firewalls also prohibit the Advisor's and Sub-Advisor's advisory 
personnel from sharing any non-public information about the management 
of the Funds with the personnel responsible for creating, monitoring, 
calculating, maintaining or disseminating the Indices (i.e., Index 
Personnel and the Index Administrator/Calculation Agent). Further, the 
Advisor and the Sub-Advisor have adopted, pursuant to rule 206(4)-7 
under the Advisers Act, written policies and procedures designed to 
prevent violations of the Advisers Act and the rules under the Advisers 
Act. The Advisor, the Sub-Advisor and the Distributor each have adopted 
or will adopt a Code of Ethics as required under rule 17j-1 under the 
Act, which contains provisions reasonably necessary to prevent Access 
Persons (as defined in rule 17j-1) from engaging in any conduct 
prohibited in rule 17j-1. In addition, the Advisor and the Sub-Advisor 
have adopted or will adopt policies and procedures to detect and 
prevent insider trading as required under section 204A of the Advisers 
Act, which are reasonably designed, taking into account the nature of 
their business, to prevent the misuse in violation of the Advisers Act, 
Exchange Act, or rules and regulations under the Advisers Act and 
Exchange Act, of material non-public information.
    4. Any Future Fund will be advised by the Advisor or an entity 
controlled by or under common control with the Advisor. Applicants will 
not offer a Future Fund unless either they have requested and received 
with respect to such Future Fund exemptive relief from the Commission 
or a no-action position from the staff of the Commission, or the Future 
Fund will be listed on an Exchange without the need for a filing under 
rule 19b-4 under the Exchange Act. In addition, any Future Fund that 
relies on any order granted pursuant to this application will comply 
with the terms and conditions of the application, including the 
following: (a) The Methodology will be publicly available, including on 
the Website; (b) once the rules of the Methodology are established, 
applicants may change them only after giving the public at least 60 
days advance notice of any change; (c) applicants have Firewalls; (d) 
the Index Administrator/Calculation Agent will not be an affiliated 
person, or an affiliated person of an affiliated person, of the Funds, 
Advisor, Sub-Advisor, Index Creator, Distributor or promoter of the 
Funds; and (e) the Indexes will be reconstituted on a fixed periodic 
basis no more frequently than quarterly.
    5. The investment objective of each Fund will be to provide 
investment results that track the performance, before fees and 
expenses, of a particular Underlying Index. The intra-day value of each 
Index will be disseminated every 15 seconds throughout the trading day 
over the Consolidated Tape on each day that the Funds are open, which 
includes any day that the Funds are required by to be open under 
section 22(e) of the Act (``Business Day''). In seeking to achieve its 
investment objective, each Fund will utilize either a replication or a 
representative sampling strategy. A Fund using a replication strategy 
generally will invest in the Component Securities in its Underlying 
Index in approximately the same weightings as in the Underlying Index. 
In certain circumstances, such as when a Component Security is illiquid 
or there are practical difficulties or substantial costs involved in 
holding every security in an Underlying Index, a Fund may use a 
representative sampling strategy pursuant to which it will invest in 
some but not all of the Component Securities.\6\ Applicants

[[Page 67406]]

anticipate that a Fund that utilizes a representative sampling strategy 
will not track the performance of its Underlying Index with the same 
degree of accuracy as an investment vehicle that invests in every 
Component Security of the Underlying Index in the same weighting as the 
Underlying Index. Applicants expect that each Fund will have a tracking 
error relative to the performance of its Underlying Index of less than 
5%.
---------------------------------------------------------------------------

    \6\ Each Fund will invest at least 90% of its assets in 
Component Securities. Each Fund may invest up to 10% of its assets 
in securities that are not Component Securities, but which the 
Advisor or Sub-Advisor believes will help the Fund track its 
Underlying Index, including futures, options and swap contracts, 
cash and cash equivalents. Certain Funds may invest in American 
Depositary Receipts or Global Depositary Receipts (collectively, 
``Depositary Receipts'') based on securities of foreign companies in 
the Underlying Index. A Fund would treat Depositary Receipts that 
represent Component Securities of its Underlying Index as Component 
Securities for purposes of any requirements related to the 
percentage of Component Securities held by a Fund.
---------------------------------------------------------------------------

    6. Shares of the Funds will be sold at a price of between $40 and 
$250 per Share in Creation Units of 50,000 Shares. All orders to 
purchase Creation Units must be placed with the Distributor by or 
through an ``Authorized Participant,'' an entity that has entered into 
an agreement with the Distributor and that is either (a) A participant 
in the continuous net settlement system of the National Securities 
Clearing Corporation, a clearing agency registered with the Commission 
or (b) a participant in the Depository Trust Company (``DTC,'' and such 
participant, ``DTC Participant''). Creation Units generally will be 
issued in exchange for an in-kind deposit of securities and cash, 
though a Fund may sell Creation Units on a cash-only basis in limited 
circumstances. An investor wishing to purchase a Creation Unit from a 
Fund will have to transfer to the Fund a ``Creation Deposit'' 
consisting of: (a) A portfolio of securities that has been selected by 
the Advisor or Sub-Advisor to correspond generally to the performance 
of the relevant Index (``Deposit Securities''); and (b) a cash payment 
to equalize any differences between the market value of the Deposit 
Securities per Creation Unit and the net asset value (``NAV'') per 
Creation Unit (``Cash Requirement'').\7\ An investor purchasing a 
Creation Unit from a Fund will be charged a fee (``Transaction Fee'') 
to prevent the dilution of the interests of the remaining shareholders 
resulting from the Fund incurring costs in connection with the purchase 
of the Creation Units.\8\ Each Fund will disclose the maximum 
Transaction Fee in its prospectus (``Prospectus'') and the method of 
calculating the Transaction Fee in its statement of additional 
information (``SAI''). No sales charges for purchases of Creation Units 
of any Fund are contemplated. The Corporation is authorized to 
implement a plan under rule 12b-1 under the Act for each of the Funds, 
which will be disclosed in the Fund's Prospectus, if implemented.
---------------------------------------------------------------------------

    \7\ On each Business Day, prior to the opening of trading on the 
Exchange, the Advisor or Sub-Advisor will make available the list of 
the names and the required number of shares of each Deposit Security 
required for the Creation Deposit for the Fund. That Creation 
Deposit will apply to all purchases of Creation Units until a new 
Creation Deposit for the Fund is announced. Each Fund reserves the 
right to permit or require the substitution of an amount of cash in 
lieu of depositing some or all of the Deposit Securities. The 
Exchange will disseminate every 15 seconds throughout the trading 
day over the Consolidated Tape an amount representing, on a per 
Share basis, the sum of the current value of the Deposit Securities 
and the estimated Cash Requirement.
    \8\ When a Fund permits a purchaser to substitute cash for 
Deposit Securities, the purchaser may be assessed a higher 
Transaction Fee to offset the brokerage and other transaction costs 
incurred by the Fund to purchase the requisite Deposit Securities.
---------------------------------------------------------------------------

    7. Orders to purchase Creation Units of a Fund will be placed with 
the Distributor who will be responsible for transmitting orders to the 
Funds. The Distributor will maintain a record of Creation Unit 
purchases. The Distributor will be responsible for issuing 
confirmations of acceptance and furnishing Prospectuses to purchasers 
of Creation Units.
    8. Persons purchasing Creation Units from a Fund may hold the 
Shares or sell some or all of them in the secondary market. Shares of 
the Funds will be listed on an Exchange and traded in the secondary 
market in the same manner as other equity securities. It is expected 
that one or more members of the Exchange will act as a specialist 
(``Specialist''), and maintain a market on the Exchange for the Shares. 
The price of Shares traded on an Exchange will be based on a current 
bid/offer market. Purchases and sales of Shares in the secondary market 
will be subject to customary brokerage commissions and charges.
    9. Applicants expect that purchasers of Creation Units will include 
institutional investors and arbitrageurs. The Specialist, in providing 
for a fair and orderly secondary market for Shares, also may purchase 
Creation Units for use in its market-making activities. Applicants 
expect that secondary market purchasers of Shares will include both 
institutional and retail investors.\9\ Applicants expect that the price 
at which the Shares trade will be disciplined by arbitrage 
opportunities created by the ability to continually purchase or redeem 
Creation Units at their NAV, which should ensure that the Shares will 
not trade at a material discount or premium in relation to their NAV.
---------------------------------------------------------------------------

    \9\ Shares will be registered in book-entry form only. DTC or 
its nominee will be the registered owner of all outstanding Shares. 
DTC or DTC Participants will maintain records reflecting the 
beneficial owners of Shares.
---------------------------------------------------------------------------

    10. Shares will not be individually redeemable. Shares will only be 
redeemable in Creation Units from a Fund. To redeem, an investor will 
have to accumulate enough Shares to constitute a Creation Unit. 
Redemption orders must be placed by or through an Authorized 
Participant. An investor redeeming a Creation Unit generally will 
receive (a) A portfolio of securities designated to be delivered for 
Creation Unit redemptions on the date that the request for redemption 
is submitted (``Redemption Securities''), and (b) a ``Cash Redemption 
Payment,'' consisting of an amount calculated in the same manner as the 
Cash Requirement. An investor may receive the cash equivalent of a 
Redemption Security in certain circumstances, such as if the investor 
is constrained from effecting transactions in the security by 
regulation or policy. A redeeming investor will pay a Transaction Fee, 
which is calculated in the same manner as a Transaction Fee payable in 
connection with purchases of Creation Units.
    11. Applicants state that neither the Corporation nor any Fund will 
be marketed or otherwise held out as a traditional open-end investment 
company or mutual fund. Rather, applicants state that each Fund will be 
marketed as an ``exchange-traded fund,'' ``investment company,'' 
``fund,'' or ``trust.'' All marketing materials that refer to 
redeemability or describe the method of obtaining, buying or selling 
Shares will prominently disclose that Shares are not individually 
redeemable and that Shares may be acquired or redeemed from the Fund in 
Creation Units only. The same type of disclosure will be provided in 
the Prospectus, SAI, shareholder reports and investor educational 
materials issued or circulated in connection with Shares. The Funds 
will provide copies of their annual and semi-annual shareholder reports 
to DTC Participants for distribution to beneficial owners of Shares.

Applicants' Legal Analysis

    1. Applicants request an order under section 6(c) of the Act 
granting an exemption from sections 2(a)(32), 5(a)(1), 22(d), and 24(d) 
of the Act and rule 22c-1 Under the Act, and under sections 6(c) and 
17(b) of the Act granting an exemption from sections 17(a)(1) and 
17(a)(2) of the Act.

[[Page 67407]]

    2. Section 6(c) of the Act provides that the Commission may exempt 
any person, security or transaction, or any class of persons, 
securities or transactions, from any provision of the Act, if and to 
the extent that such exemption is necessary or appropriate in the 
public interest and consistent with the protection of investors and the 
purposes fairly intended by the policy and provisions of the Act. 
Section 17(b) of the Act authorizes the Commission to exempt a proposed 
transaction from section 17(a) if evidence establishes that the terms 
of the transaction, including the consideration to be paid or received, 
are reasonable and fair and do not involve overreaching on the part of 
any person concerned, and the proposed transaction is consistent with 
the policies of the registered investment company and the general 
provisions of the Act.

Sections 5(a)(1) and 2(a)(32) of the Act

    3. Section 5(a)(1) of the Act defines an ``open-end company'' as a 
management investment company that is offering for sale or has 
outstanding any redeemable security of which it is the issuer. Section 
2(a)(32) of the Act defines a redeemable security as any security, 
other than short-term paper, under the terms of which the holder, upon 
its presentation to the issuer, is entitled to receive approximately 
his proportionate share of the issuer's current net assets, or the cash 
equivalent. Because Shares will not be individually redeemable, 
applicants request an order that would permit the Corporation to 
register as an open-end management investment company and issue Shares 
that are redeemable in Creation Units only. Applicants state that 
investors may purchase Shares in Creation Units and redeem Creation 
Units from each Fund. Applicants further state that because the market 
price of Shares will be disciplined by arbitrage opportunities, 
investors should be able to sell Shares in the secondary market at 
prices that do not vary substantially from their NAV.

Section 22(d) of the Act and Rule 22c-1 Under the Act

    4. Section 22(d) of the Act, among other things, prohibits a dealer 
from selling a redeemable security, which is currently being offered to 
the public by or through a principal underwriter, except at a current 
public offering price described in the prospectus. Rule 22c-1 under the 
Act generally requires that a dealer selling, redeeming or repurchasing 
a redeemable security do so only at a price based on its NAV. 
Applicants state that secondary market trading in Shares will take 
place at negotiated prices, not at a current offering price described 
in the Prospectus, and not at a price based on NAV. Thus, purchases and 
sales of Shares in the secondary market will not comply with section 
22(d) of the Act and rule 22c-1 under the Act. Applicants request an 
exemption under section 6(c) from these provisions.
    5. Applicants assert that the concerns sought to be addressed by 
section 22(d) of the Act and rule 22c-1 under the Act with respect to 
pricing are equally satisfied by the proposed method of pricing Shares. 
Applicants maintain that the provisions of section 22(d), as well as 
those of rule 22c-1, appear to have been designed to (a) prevent 
dilution caused by certain riskless trading schemes by principal 
underwriters and contract dealers, (b) prevent unjust discrimination or 
preferential treatment among buyers, and (c) ensure an orderly 
distribution of investment company shares by eliminating price 
competition from dealers offering shares at less than the published 
sales price and repurchasing shares at more than the published 
redemption price.
    6. Applicants believe that none of these purposes will be thwarted 
by permitting Shares to trade in the secondary market at negotiated 
prices. Applicants state that (a) Secondary market trading in Shares 
does not involve the Funds as parties and cannot result in dilution of 
an investment in Shares, and (b) to the extent different prices exist 
during a given trading day, or from day to day, such variances occur as 
a result of third-party market forces, such as supply and demand. 
Therefore, applicants assert that secondary market transactions in 
Shares will not lead to discrimination or preferential treatment among 
purchasers. Finally, applicants contend that the proposed distribution 
system will be orderly because arbitrage activity will ensure that the 
difference between the market price of Shares and their NAV remains 
narrow.

Section 24(d) of the Act

    7. Section 24(d) of the Act provides, in relevant part, that the 
prospectus delivery exemption provided to dealer transactions by 
section 4(3) of the Securities Act does not apply to any transaction in 
a redeemable security issued by an open-end investment company. 
Applicants request an exemption from section 24(d) to permit dealers 
selling Shares to rely on the prospectus delivery exemption provided by 
section 4(3) of the Securities Act.\10\
---------------------------------------------------------------------------

    \10\ Applicants state that they do not seek relief from the 
prospectus delivery requirement for non-secondary market 
transactions, such as purchases of Shares from the Funds or an 
underwriter. Applicants state that the Prospectus will caution 
persons purchasing Creation Units that some activities on their 
part, depending on the circumstances, may result in their being 
deemed statutory underwriters and subject them to the prospectus 
delivery and liability provisions of the Securities Act. For 
example, a broker-dealer firm and/or its client may be deemed a 
statutory underwriter if it takes Creation Units after placing an 
order with the Distributor, breaks them down into the constituent 
Shares and sells them directly to its customers, or if it chooses to 
couple the creation of new Shares with an active selling effort 
involving solicitation of secondary market demand for Shares. The 
Prospectus will state that whether a person is an underwriter 
depends upon all the facts and circumstances pertaining to that 
person's activities. The Prospectus also will state that dealers who 
are not ``underwriters'' but are participating in a distribution (as 
contrasted to ordinary secondary market trading transactions), and 
thus dealing with Shares that are part of an ``unsold allotment'' 
within the meaning of section 4(3)(C) of the Securities Act, would 
be unable to take advantage of the prospectus delivery exemption 
provided by section 4(3) of the Securities Act.
---------------------------------------------------------------------------

    8. Applicants state that Shares will be listed on an Exchange and 
will be traded in a manner similar to other equity securities, 
including the shares of closed-end investment companies. Applicants 
note that dealers selling shares of closed-end investment companies in 
the secondary market generally are not required to deliver a prospectus 
to the purchaser. Applicants contend that Shares, as a listed security, 
merit a reduction in the compliance costs and regulatory burdens 
resulting from the imposition of prospectus delivery obligations in the 
secondary market. Because Shares will be exchange-listed, prospective 
investors will have access to several types of market information about 
Shares. Applicants state that information regarding market price and 
volume will be continually available on a real-time basis throughout 
the day on computer screens of brokers and other electronic services. 
The previous day's closing price and volume information for Shares also 
will be published daily in the financial section of newspapers. In 
addition, the Web site will include, for each Fund, the prior Business 
Day's NAV, the mid-point of the bid-ask spread for a Share at the time 
of calculation of the NAV (``Bid/Ask Price''), and a calculation of the 
premium or discount of the closing price against such Bid/Ask Price, as 
well as data in chart format displaying the frequency distribution of 
discounts and premiums of the Bid/Ask Price against the NAV, within 
appropriate ranges, for each of the four previous calendar quarters.
    9. Investors also will receive a short product description 
(``Product Description''), describing a Fund and its

[[Page 67408]]

Shares. Applicants state that, while not intended as a substitute for a 
Prospectus, the Product Description will contain information about 
Shares that is tailored to meet the needs of investors purchasing 
Shares in the secondary market. The Product Description will 
prominently disclose that the Indexes are created and sponsored by an 
affiliated person of the Advisor.

Sections 17(a)(1) and (2) of the Act

    10. Section 17(a) of the Act generally prohibits an affiliated 
person of a registered investment company, or an affiliated person of 
such a person, from selling any security to or purchasing any security 
from the company. Section 2(a)(3) of the Act defines ``affiliated 
person'' to include any person directly or indirectly owning, 
controlling or holding with power to vote 5% or more of the outstanding 
voting securities of the other person, and any person directly or 
indirectly controlling, controlled by or under common control with the 
other person. Section 2(a)(9) of the Act provides that a control 
relationship will be presumed where one person owns more than 25% of 
another person's voting securities.
    11. Applicants request an exemption from section 17(a) to the 
extent necessary to permit (a) persons who are affiliated persons of a 
Fund solely by virtue of holding with the power to vote 5% or more, or 
more than 25%, of the Shares of a Fund (``First-Tier Affiliates'') and 
(b) affiliated persons of First-Tier Affiliates who are not otherwise 
affiliated with the Fund, and persons who are affiliated persons of a 
Fund solely by virtue of holding with the power to vote 5% or more, or 
more than 25%, of the outstanding voting securities of other registered 
investment companies (or series thereof) advised by the Advisor 
(``Second-Tier Affiliates'') to purchase and redeem Creation Units 
through in-kind purchases and sales of securities. Applicants contend 
that no useful purpose would be served by prohibiting the First- and 
Second-Tier Affiliates from purchasing or redeeming Creation Units 
through in-kind transactions. The deposit procedure for in-kind 
purchases and the redemption procedure for in-kind redemptions will be 
the same for all purchases and redemptions. Deposit Securities and 
Redemption Securities will be valued in the same manner as the 
Portfolio Securities. Therefore, applicants state, the in-kind 
purchases and redemptions for which relief is requested will afford no 
opportunity for the affiliated persons of a Fund, or the affiliated 
persons of such affiliated persons, described above, to effect a 
transaction detrimental to other holders of Shares. Applicants also 
believe that these in-kind purchases and redemptions will not result in 
self-dealing or overreaching of the Fund.

Applicants' Conditions

    Applicants agree that any order granting the requested order will 
be subject to the following conditions:
    1. Applicants will not register a Future Fund by means of filing a 
post-effective amendment to the Corporation's registration statement or 
by any other means, unless either (a) Applicants have requested and 
received with respect to such Future Fund, either exemptive relief from 
the Commission or a no-action letter from the Division of Investment 
Management of the Commission, or (b) the Future Fund will be listed on 
an Exchange without the need for a filing pursuant to rule 19b-4 under 
the Exchange Act.
    2. Each Fund's Prospectus and Product Description will clearly 
disclose that, for purposes of the Act, Shares are issued by the Funds 
and that the acquisition of Shares by investment companies is subject 
to the restrictions of section 12(d)(1) of the Act, except as permitted 
by an exemptive order that permits registered investment companies to 
invest in a Fund beyond the limits of section 12(d)(1), subject to 
certain terms and conditions, including that the registered investment 
company enter into an agreement with the Fund regarding the terms of 
the investment.
    3. As long as the Corporation operates in reliance on the requested 
order, the Shares will be listed on an Exchange.
    4. Neither the Corporation nor any Fund will be advertised or 
marketed as an open-end investment company or a mutual fund. Each 
Fund's Prospectus will prominently disclose that Shares are not 
individually redeemable shares and will disclose that the owners of 
Shares may acquire those Shares from a Fund and tender those Shares for 
redemption to a Fund in Creation Units only. Any advertising material 
that describes the purchase or sale of Creation Units or refers to 
redeemability will prominently disclose that Shares are not 
individually redeemable and that owners of Shares may acquire those 
Shares from a Fund and tender those Shares for redemption to a Fund in 
Creation Units only.
    5. The Web site maintained for the Corporation, which is and will 
be publicly accessible at no charge, will contain the following 
information, on a per Share basis, for each Fund: (a) The prior 
Business Day's NAV and the Bid/Ask Price and a calculation of the 
premium or discount of the Bid/Ask Price at the time of calculation of 
the NAV against such NAV; and (b) data in chart format displaying the 
frequency distribution of discounts and premiums of the daily Bid/Ask 
Price against the NAV, within appropriate ranges, for each of the four 
previous calendar quarters. In addition, the Product Description for 
each Fund will state that the website for the Fund has information 
about the premiums and discounts at which the Shares have traded.
    6. The Prospectus and annual report for each Fund will also 
include: (a) The information listed in condition 5(b), (i) in the case 
of the Prospectus, for the most recently completed year (and the most 
recently completed quarter or quarters, as applicable) and (ii) in the 
case of the annual report, for the immediately preceding five years, as 
applicable; and (b) the following data, calculated on a per Share basis 
for one, five and ten year periods (or life of the Fund), (i) the 
cumulative total return and the average annual total return based on 
NAV and Bid/Ask Price, and (ii) the cumulative total return of the 
relevant Underlying Index.
    7. Before a Fund may rely on the order, the Commission will have 
approved, pursuant to rule 19b-4 under the Exchange Act, an Exchange 
rule requiring Exchange members and member organizations effecting 
transactions in Shares to deliver a Product Description to purchasers 
of Shares.

    For the Commission, by the Division of Investment Management, 
under delegated authority.
Nancy M. Morris,
Secretary.
[FR Doc. E6-19666 Filed 11-20-06; 8:45 am]

BILLING CODE 8011-01-P